Mesoblast Limited's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Mesoblast Limited's ROA in the fourth quarter of 2025?
Mesoblast Limited recorded a cumulative net loss of $-102 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on assets (ROA) of -13.24%.

However, within the Healthcare sector 312 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 3391.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Jun 30 2024) IV. Quarter
Y / Y Total Assets Change	4.71 %	61.87 %	0.1 %	61.87 %	-0.84 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-102	-88	-88	-88	-88
Return On Assets (TTM)	-13.24 %	-11.53 %	-12.77 %	-12.78 %	-14.32 %
MESO's Total Ranking	# 3391	#	#	#	# 3530
Total Assets (TTM) in million	782	778	749	778	747
Seq. Total Assets Change	0.57 %	3.86 %	-3.72 %	4.12 %	55.46 %
Seq. Net Income Change	-	-	-	-	-

MESO's 5 Years Annual ROA >> Back to MESO Management Effectiveness >> Compare MESO ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 32
Sector	# 313
Overall	# 3347

Return On Assets Statistics
High	Average	Low
-10.62 %	-12.84 %	-13.8 %
(Jun 30 2020)		(Jun 30 2022)

Financial Statements
Mesoblast Limited's Assets	$ 782 million	MESO's Balance sheet
Mesoblast Limited's Income	$ -102 million	Quarterly MESO's Income Statement
MESO's Income by Division		See MESO's Income by Division

Annual Return On Assets	(Jun 30 2025) FY 2025	(Jun 30 2024) FY 2024	(Jun 30 2023) FY 2023	(Jun 30 2022) FY 2022	(Jun 30 2021) FY 2021
Y / Y Total Assets Change	18.29 %	0.1 %	1.27 %	-9.01 %	1.55 %
Total Assets in million	886	749	748	739	812
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-102	-88	-82	-91	-99
Annual Return On Assets	-11.53 %	-11.74 %	-10.94 %	-12.36 %	-12.17 %

MESO's 5 Years Annual ROA >> Back to MESO Management Effectiveness >> Compare MESO ROA to its Competitors

More Return On Assets Ratios
MESO's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MESO's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MESO's Competitors
Subscribers only: Roa for Mesoblast Limited's Suppliers
Subscribers only: Return On Assets for MESO's Customers

You may also want to know
MESO's Roi	MESO's Inventory Turnover Ratio	MESO's Growth Rates	MESO's Dividend Comparisons
	MESO's Profitability Ratios	MESO's Asset Turnover Ratio	MESO's Dividend Growth
MESO's Roe	MESO's Valuation Ratios	MESO's Financial Strength Ratios	MESO's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector

ROA

Date modified: 2026-07-07T12:24:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.